In his weekly clinical update, Dr. Griffin discusses the CDC HIV surveillance report, FDA voted in favor of approving the Abrysvo vaccine, canine olfactory detection of SARS-CoV-2-infected humans, safety of the BNT162b2 COVID-19 vaccine in children aged 5 to 17 years, and statement on the antigen composition of COVID-19 vaccines.

Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

• HIV surveillance report (CDC)
• FDA voted in favor of approving Abrysvo vaccine (Pfizer)
• Canine olfactory detection of SARS-CoV-2-infected humans (Annals of Epidemiology)
• Safety of the BNT162b2 COVID-19 vaccine in children (JAMA)
• Statement on the antigen composition of COVID-19 vaccines (WHO)
• Contribute to our FIMRC fundraiser at PWB
• Letters read on TWiV 1010
• Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to [email protected]